Selected article for: "accelerated vaccine and acute sars respiratory syndrome"
Author: Lee, Pureum; Kim, Doo-Jin
Title: Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19
  • Cord-id: m9ynza4u
  • Document date: 2020_7_22
    • ID: m9ynza4u
    Snippet: The recent emergence of the novel coronavirus (CoV) or severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a global threat to human health and economy. As of June 26, 2020, over 9.4 million cases of infection, including 482,730 deaths, had been confirmed across 216 countries. To combat a devastating virus pandemic, numerous studies on vaccine development are urgently being accelerated. In this review article, we take a brief look at the characteristics of SARS-CoV-2 in comparison
    Document: The recent emergence of the novel coronavirus (CoV) or severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a global threat to human health and economy. As of June 26, 2020, over 9.4 million cases of infection, including 482,730 deaths, had been confirmed across 216 countries. To combat a devastating virus pandemic, numerous studies on vaccine development are urgently being accelerated. In this review article, we take a brief look at the characteristics of SARS-CoV-2 in comparison to SARS and Middle East respiratory syndrome (MERS)-CoVs and discuss recent approaches to coronavirus disease-2019 (COVID-19) vaccine development.

    Search related documents:
    Co phrase search for related documents
    • ab response and acid vaccine: 1
    • ab response and acute respiratory syndrome: 1, 2, 3, 4
    • ab response and acute sars respiratory syndrome: 1, 2, 3, 4
    • ab response and ad adenovirus: 1
    • ab response and adaptive immune response: 1
    • ab response and local immune response: 1